Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021

File(s)

race reporting MG BJU 9-17.docx (32.79 KB)

Accepted version

Show more

Author(s)

Glover, Michael

Hui, Gavin

Chiang, Ryan

Savage, Philip

Krell, Jonathan

more

Type

Journal Article

Date Issued

2022-02

Date Acceptance

2021-11-01

Citation

BJU International, 2022, 129 (2), pp.168-170

URI

http://hdl.handle.net/10044/1/92906

URL

https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.15629

DOI

https://www.dx.doi.org/10.1111/bju.15629

ISSN

1464-4096

Publisher

Wiley

Start Page

168

End Page

170

Journal / Book Title

BJU International

Volume

129

Issue

2

Copyright Statement

© 2021 The Authors BJU International © 2021 BJU International. This is the accepted version of the following article: Glover, M., Hui, G., Chiang, R., Savage, P., Krell, J., Julve, M., Grivas, P., Lythgoe, M. and Khaki, A.R. (2021), Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 202, which has been published in final form at https://doi.org/10.1111/bju.15629

Sponsor

Ovarian Cancer Action

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000719128600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Grant Number

n/a

Subjects

Science & Technology

Life Sciences & Biomedicine

Urology & Nephrology

Publication Status

Published

Date Publish Online

2021-11-08